Can GLP-1 drugs help tackle addiction?
New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.
Newsletters and Deep Dive digital magazine
New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.
The UK has awarded nearly £50m in funding for equipment to help the NHS carry out commercial clinical trials, with a focus on primary care capacity.
International cancer experts have called for big changes to bile duct cancer, which kills three-quarters of patients within a year of diagnosis.
uniQure looks like it may have to run another trial of its Huntington's disease gene therapy AMT-130, delaying the highly anticipated programme.
A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Editor's Picks
Newsletters and Deep Dive
digital magazine